TRxADE Health (NASDAQ: MEDS), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, is planning on releasing its financial information for Q2 2022 after the market closes on July 25, 2022. The company announced that it will release the information and discuss it during an earnings conference call and webcast scheduled to start at 5 p.m. ET on July 25, 2022. TRxADE management will host the event, which will include time for questions from call participants. Those interested in participating can call 1-877-425-9470 in the United States or 1-201-389-0878 internationally, then use conference ID 13731433. Participants are encouraged to call 10 minutes before the webcast is scheduled to begin to ensure their participation. A replay of the call will be available through Aug. 25, 2022; those interested in listening to the replay can dial 1-844-512-2921 in the United States or 1-412-317-6671 when calling internationally and enter replay pin number 13731433. A webcast version of the replay will be available on the company’s website in the IR section.
To view the web conference, visit https://ibn.fm/kWwZh
To view the full press release, visit https://ibn.fm/t7Fgk
About TRxADE Health Inc
TRxADE Health is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States. The company operates the TRxADE drug procurement marketplace serving more than 13,475 members nationwide, fostering price transparency and, under the Bonum Health brand, offering patient-centric telehealth services. For more information about the company, please visit www.Trxade.com and www.BonumHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
